Le Lézard
Classified in: Business
Subject: BUSINESS CONTRACTS

Boralex commissions 25 MW of solar and wind farms in France


PARIS, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Boralex Inc. ("Boralex" or the "Company") (TSX: BLX) is pleased to announce the commissioning of the Grange du Causse solar farm and the Mont de Bézard II wind farm, for a total capacity of 25 MW. These commissionings bring Boralex's installed capacity in France to 1,133 MW and its total capacity worldwide to 2,509 MW.

"We are very pleased to end the year with two commissionings, in time for them to become part of France's energy mix as winter approaches. The Grange du Causse solar farm, which we built from scratch under a power purchase agreement (corporate PPA), will generate competitive green energy for our customer, METRO France, while the Mont de Bézard II wind farm repowering has allowed us to double the facility's production capacity and lower its operating costs thanks to the use of modern wind turbines. It is worth noting that the commissioning of these two facilities means new renewable energy production capacity for a system under high pressure at risk of power cuts this winter. Renewables are not only important for the decarbonization of our industry, they are also the key to our energy sovereignty," said Nicolas Wolff, Executive Vice President and General Manager of Boralex, Europe.

Grange du Causse is the first Boralex project developed under a corporate PPA. Through the PPA, Boralex, a leader and pioneer in France's renewable energy sector, will supply METRO France, the leading independent food service provider, with the power generate by the solar power plant for 20 years, starting in 2024.

Initially commissioned in 2007, the wind farm has seen its capacity doubled through the replacement of its original equipment with the same number of 4.2 MW wind turbines. Thanks to its new configuration, the wind farm will produce the equivalent of the energy consumption of more than 40,000 French inhabitants and avoid approximately 14,000 tons of CO2 emissions. It is also worth noting that five of the six original wind turbines will find new life on the second-hand market, while the sixth will be used for maintenance technician training purposes in the south of France.

About Boralex

At Boralex, we have been providing affordable renewable energy accessible to everyone for over 30 years. As a leader in the Canadian market and France's largest independent producer of onshore wind power, we also have facilities in the United States and development projects in the United Kingdom. Over the past five years, our installed capacity has more than doubled to 2.5 GW. We are developing a portfolio of close to 4 GW in wind and solar projects and close to 800 MW in storage projects, guided by our values and our corporate social responsibility (CSR) approach. Through profitable and sustainable growth, Boralex is actively participating in the fight against global warming. Thanks to our fearlessness, our discipline, our expertise and our diversity, we continue to be an industry leader. Boralex's shares are listed on the Toronto Stock Exchange under the ticker symbol BLX.

For more information, visit www.boralex.com or www.sedar.com. Follow us on Facebook, LinkedIn and Twitter.

For more information:

Media Investor Relations
Camille Laventure
Advisor, External Communications
Boralex Inc.
438-883-8580
[email protected]  
Stéphane Milot
Senior Director ? Investor Relations
Boralex Inc.
514 213-1045
[email protected]
  
Media ? France (Agency)
Virginie Raison
PR Consultant
Oxygen
06 65 27 33 52
[email protected]
 
  

Source: Boralex Inc.



These press releases may also interest you

16 mai 2024
OKX, a leading Web3 technology company, has issued updates for May 16, 2024. OKX Launches Cryptopedia Season 18, Offering Users Up to...

16 mai 2024
Mr. Narongsak Jivakanun (Second from left), CEO of PTT Global Chemical Public Company Limited (GC) presided over the signing ceremony and extended his congratulations to Krungthai Bank and NatureWorks - a joint venture of GC and a leading...

16 mai 2024
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...

16 mai 2024
Velan Inc. ("Velan" or the "Company"), a world-leading manufacturer of industrial valves, announced today its financial results for its fourth quarter and fiscal year ended February 29, 2024. All amounts are expressed in U.S. dollars unless...

16 mai 2024
TSX VENTURE COMPANIES BULLETIN V2024-1467 DECISIVE DIVIDEND CORPORATION ("DE")BULLETIN TYPE:  Declaration of DividendBULLETIN DATE:  May 16, 2024TSX Venture Tier 2 Company The Issuer has declared the following dividend: Dividend per common share:...

16 mai 2024
CHICANE CAPITAL II CORP. (the "Corporation") is pleased to announce the filing of a final prospectus for its initial public offering. Access to the prospectus and any amendment thereto is provided in connection with the Corporation's initial public...



News published on and distributed by: